We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 7 start-ups with an aggregate funding of $1.2b. The average funding per company in this subset is $169.3m.
Last update to the database: Feb 18, 2025. See changelog.
Freenome is a San Francisco-based company which uses genetic analysis for early cancer detection and risk assessment.
8
Funding Rounds
$967.6m
Money raised
Sanguine is a company that has the mission to accelerate medical research by eliminating the barriers to patient participation.
1
Funding Rounds
$1.0m
Money raised
AI-powered, FDA-cleared blood cell morphology platform replaces manual lab microscopy, helping hematologists and hematopathologists to detect cancers and blood-related diseases.
2
Funding Rounds
$18.5m
Money raised
NuvOx Pharma is an oxygen therapeutics company founded in 2008 by David Wilson.
10
Funding Rounds
$13.5m
Money raised
A biotechnology company developing treatments for hematology and oncology diseases
1
Funding Rounds
$30.0m
Money raised
The Hemarina technological platform is based on the peculiarities of the purified hemoglobin of lugworms, Arenicola marina . Its structure is comparable to that of human hemoglobin, however it is distinguished by: its extracellular character (it is not contained in a red blood cell), and therefore universal (compatibility with all blood groups) its ability to bind 40 times more oxygen than human hemoglobin its particularly small size: 250 times smaller than the human red blood cell
2
Funding Rounds
$4.8m
Money raised
A biopharmaceutical company developing scientific, clinical and commercial oxygen-therapeutic agents
2
Funding Rounds
$150.0m
Money raised